Bradykinin b2 receptor is involved in the late phase of preconditioning in rabbit heart

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 7, 2001, Pages 1355-1362

  Kositprapa, Chartchai ^a   Ockaili, Ramzi A ^a   Kukreja, Rakesh C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B2 receptor; Bradykinin; Ischemia; Preconditioning

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; TETRAZOLIUM; BRADYKININ RECEPTOR; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; RECEPTOR INTRINSIC ACTIVITY; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HEART INFARCTION; HEMODYNAMICS; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; BRADYKININ; HEMODYNAMIC PROCESSES; INFUSIONS, INTRA-ARTERIAL; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; RABBITS; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; REPERFUSION;

EID: 0034743525     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1396     Document Type: Article

References (37)

1. Preconditioning with ischemia: A delay of Lethal cell injury in ischemic myocardium
2. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction
3. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning
4. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes
5. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning
6. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart
7. Ischemic preconditioning and morphine-induced cardio-protection involve the delta (delta)-opioid receptor in the intact rat heart
8. Monophosphoryl lipid A induces pharmacologic "preconditioning" in rabbit hearts without concomitant expression of 70-kDa heat shock protein
9. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: Evidence from pharmacological inhibition and gene knockout mice
10. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice
11. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: Role of nitric oxide
12. ATP channel
13. Local intracoronary infusions of bradykinin protbundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs
14. Role of bradykinin in myocardial preconditioning
15. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation
16. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors
17. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts
18. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: Influence of enalaprilat
19. Bradykinin and not cholecystokinin stimulates exaggerated prostanoid release from the inflamed rabbit gallbladder
20. Kinin B(1) receptors and the cardiovascular system: Regulation of expression and function
21. Myocardial preconditioning: Basic concepts and potential mechanisms
22. Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels
23. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart
24. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning
25. Bradykinin protects the rabbit heart after cardioplegic ischemia via NO-dependent pathways
26. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart
27. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril
28. Reduction of myocardial infarct size in rabbits by ramiprilat: Reversal by the bradykinin antagonist HOE 140
29. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors
30. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty
31. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs
32. Infarct size limitation by bradykinin receptor activation is mediated by the mitochondrial but not by the sarcolemmal K(ATP) channel
33. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: Evidence from gene-knock-out mice
34. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction
35. Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K(+) channels in rabbit heart
36. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart
37. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene